Open-Label Proof of Concept Study of VP-315 in Basal Cell Carcinoma

Clinical trial NCT05188729 · COMPLETED

Trial details

NCT number: NCT05188729
Sponsor: Verrica Pharmaceuticals Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Basal Cell Carcinoma Skin Cancer Cancer of the Skin, Basal Cell Cancer of the Skin Carcinoma

Start date: 2022-02-01
Primary completion: 2024-04-15
Enrollment: 92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.